Contact
Please use this form to send email to PR contact of this press release:
Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor
TO:
Please use this form to send email to PR contact of this press release:
Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor
TO: